Suchergebnisse - "Abbaspour Kasgari, Hamideh"

PubPharm (8)

1

Brucella pleurisy : An extremely rare complication of brucellosis

enthalten in: Clinical case reports | 2022

von Alikhani, A. | Abbaspour Kasgari, H. | Majidi, H. | +1

2

Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients : a randomized double-blind clinical trial (DISCOVER)

enthalten in: The Journal of antimicrobial chemotherapy | 2022

von Mobarak, S. | Salasi, M. | Hormati, A. | +69

3

Brucella pleurisy : An extremely rare complication of brucellosis

enthalten in: Clinical Case Reports | 2022

von Alikhani, A. | Abbaspour Kasgari, H. | Majidi, H. | +1

4

Erratum Erratum to : Sofosbuvir/daclatasvir regimens for the treatment of COVID-19: an individual patient data meta-analysis

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Simmons, B. | Wentzel, H. | Mobarak, S. | +7

ErratumFor: J Antimicrob Chemother. 2021 Jan 19;76(2):286-291. - PMID 33063117

5

Sofosbuvir/daclatasvir regimens for the treatment of COVID-19 : an individual patient data meta-analysis

enthalten in: The Journal of antimicrobial chemotherapy | 2021

von Simmons, B. | Wentzel, H. | Mobarak, S. | +7

ErratumIn: J Antimicrob Chemother. 2021 May 12;76(6):1653. - PMID 33704468

6

Comparison of the Efficacy and Safety of Atazanavir/Ritonavir Plus Hydroxychloroquine with Lopinavir/Ritonavir Plus Hydroxychloroquine in Patients with Moderate COVID-19, A Randomized, Double-blind Clinical Trial

enthalten in: Iranian journal of pharmaceutical research : IJPR | 2021

von Nekoukar, Z. | Ala, S. | Moradi, S. | +7

7

Evaluation of the efficacy of sofosbuvir plus daclatasvir in combination with ribavirin for hospitalized COVID-19 patients with moderate disease compared with standard care : a single-centre, randomized controlled trial

enthalten in: The Journal of antimicrobial chemotherapy | 2020

von Abbaspour Kasgari, H. | Moradi, S. | Shabani, A. | +13

8

Evaluating the Effect of Dexmedetomidine on Hemodynamic Status of Patients with Septic Shock Admitted to Intensive Care Unit : A Single-Blind Randomized Controlled Trial

enthalten in: Iranian journal of pharmaceutical research : IJPR | 2020

von Gheibi, S. | Ala, S. | Heydari, F. | +3

1
[1]